Title: Prophylaxis for Atrial fibrillation in PostCABG patients
1Prophylaxis for Atrial fibrillation in Post-CABG
patients
ICU reading
2Post CABG Atrial fibrillation
- Incidence 11-40
- Consequences
- Longer LOS ( 13.95 days 8.5 days)
- Increase stroke incidence( 2.6 1.2)
- potential morbidities throboembolic events, CHF,
cardiogenic shock , coronary ischemia - J of clinical pharm and thera (2002)27,21-37
3Prophylaxis agents
- Beta-blocker standard
- reduce hyperadrenergic state after CABG
- Prevent withdrawal and rebound hypersensitivity
- Sotalol
- Magnesium sulfate
- Amiodarone
- Procainamide
- Pacemaker
- Digitalis,Verapamilno consistent benefit
4ACC/AHA guidelines for CABG surgery 1475
5Beta blocker
- Meta-analysis of 19 beta-blocker trial Afib
markly reduced (odds ratio 0.28) - Exclusion patients asthma, COPD, DM, CHF
- common among patients undergoing cardiac surgery
and limit the clinical utility of prophylaxis
with beta-blockers
6meta-analysis of antiarrhythmic therapy in the
prevention of postoperative Afib, LOS, costs,
CVA, and mortality
- 13 randomized, controlled, double blind trials
between Jan 1997 March 2001 - 1783 patients enrolled
- CABG1569 , valvular surgery87, both117, other
10
AmerJCard Vol.91 May 1, 2003
7Results incidence of post op AFib
8Estimated effects of antiarrhythmic therapies on
hospital length of stay
9Estimated effects of antiarrhythmic therapies of
hospital costs
10meta-analysis of antiarrhythmic therapy in the
prevention of postoperative Afib, LOS, costs,
CVA, and mortality
- Conclusion
- Incidence Overall significant decrease of 0.52
in the treatment group - Single tx decrease AF significantly/
nonsignificantly - LOS overall 1.0/- 0.2 day decrease in (p lt
0.001) - the incidence of stroke or mortality No
significant effect - Disparate results in a single tx group
11Amiodarone for prophylaxis of A fib
- Several regimens
- IV
- oral
- Pre-operative
- Post-operative
- IV Oral
12IV Amiodarone
- Hohnloser et al. placebo-controlled study of IV
amiodarone (77 patients) - infusion began after the completion of the
surgical procedure and significantly reduced the
incidence of Afib( 5 21). - amiodarone was discontinued in 18 percent of
patients because of side effects - Other studies bradycardia, cardiovascular
instability
13Oral Amiodarone Daoud et al
- amiodarone 600 mg QD for seven days, then 200 mg
QD until discharge - double-blind, randomized trial
- 124 patients oral amiodarone (64 patients) or
placebo (60 patients) - Mean (SD) pre-op total dose of Amiodarone
4.8(0.96)g over a period of 13/-7days
NEJM Vol 337 num 25 1785-1791
14Oral Amiodarone
- reduced the incidence of Afib by 50
percent(2553) - significantly reduced the LOS(1.4d) and total
cost (8116) - reduced symptomatic episodes of Afib after
discharge - not increase the risk of intraoperative or
postoperative complications
15Oral Amiodarone
- not associated with proarrhythmia or serious
adverse reactions - In pts with Afib reduced the ventricular rate
significantly - Short-term low-dose oral amiodarone is not
associated with the complications of intravenous
administration - limitation the requirement of a seven-day
preoperative treatment period.
16Clinical pathway of oral Amiodarone prophylaxis
- Pathway group Sep 1998Jan 1999(127)
- Control group Jan 1998April 1998(102)
Amer J of Card Vol. 89 May 1 , 2002
17Amer J of Card Vol. 89 May 1 , 2002
18Oral Amiodarone prophylaxis
- Elective Amiodarone 200 mg PO tid for 7 days,
then 200 mg PO QD beginning immediately post op
till discharge - Non-elective Amiodarone 600mg PO tid for 3 days,
then 200mg PO QD beginning immediately post op
till discharge
19Results decrease of post op Afib
20- Result
- Significant reduction in the incidence of post-op
AF( 13.4 30.7) - Incidence of post-op AF, LOS and cost were
similar for pathway patients stratified by pre-op
or post op administration of Amiodarone. -
21- Median post-op LOS 5 d 5 d
- Median hospital costs 1.081.0( p0.006)
- In Pt with post-op AFmedian LOS10d 6d
- (p0.006)
- Prolonged ventilator use( gt24hr) and reintubation
in pathway group- increased incidence of of
pneumonia (Only one case in pathway group may be
due to Amiodarone pul toxicity)
22Time to choose Amiodarone for postoperative
atrial fibrillation??
- Q1 Is amiodarone more potent
- Q2 Is Amiodarone more cost- effective
23Q1 Is Amiodarone more potent
- very little information currently available
- meta-analysis of amiodarone versus sotalol no
difference in the incidence of AF or , LOS, or
adverse drug reaction between the drugs. - randomized trial of amiodarone against digoxin
and metoprolol both regimens proved effective
at reducing the incidence of AF. AF was less
frequent in the amiodarone arm of this study (8
vs 16), but insignificant - amiodarone against propanolol amiodarone was
superior for preventing PAF, but not for length
of stay.
J of Thorac and CArdiov Surg June 2003
24Q2 Is Amiodarone cost- effective
- even more poorly answered at this point
- It has not yet been determined whether it is more
potent or cost-effective than -blockers or other
class III antiarrhythmic drugs already in use.
25Time to choose Amiodarone for postoperative
atrial fibrillation??
- standard prophylaxis for PAF now the routine
administration of beta-blockers - Amiodarone reserved for blockade contraindicated
or poorly tolerate the drug( poor ventricular
function, congestive heart failure, severe lung
disease, thyroid disease, allergy) - Selective patients high risk ??
26 - Thank you for your attention!!